Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Emerging research suggests that GLP-1 receptor agonists can cross the blood-brain barrier, making them potential treatments for neuroinflammatory and neurodegenerative diseases like Alzheimers, Parkinsons, and multiple sclerosis (MS)
When participants immune cells were exposed to tuberculosis bacteria in laboratory testing, bacterial growth was reduced in the cells from those taking ReadiSorb and grew in the cells from those taking placebo, suggesting enhanced immune defense activity
a bunch of other things can really change how fast you see results
Keep the samples on ice while preparing the assay, and work quickly once the samples are diluted
One caveat before you buy: Pratt notes that people with kidney disease or abnormal kidney labs should check with a health care professional first
